# ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack

> **NCT06118281** · PHASE3 · RECRUITING · sponsor: **Novo Nordisk A/S** · enrollment: 10000 (estimated)

## Conditions studied

- Cardiovascular Risk
- Acute Myocardial Infarction (AMI)

## Interventions

- **DRUG:** Ziltivekimab
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06118281
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-25
- **Primary completion:** 2026-12-14
- **Final completion:** 2026-12-14
- **Target enrollment:** 10000 (ESTIMATED)
- **Last updated:** 2026-04-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06118281

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06118281, "ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06118281. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*